Gena Wang Stock Analyst Profile - Barclays Research Coverage - Stocknear

Gena Wang

Stock Analyst at Barclays

(4.02)
# 2024
Out of 5,506 analysts
268
Total ratings
Success rate
Average return

44 Stocks

Name Action PT Current % Upside Ratings Updated
KOD Kodiak Sciences
Upgrades: Equal-Weight
7 17
15.06 12.88% 10 Sep 25, 2025
IONS Ionis Pharmaceutical...
Maintains: Overweight
78 80
69.15 15.69% 13 Sep 23, 2025
CYTK Cytokinetics
Maintains: Overweight
53 71
56.97 24.63% 3 Sep 3, 2025
RGNX Regenxbio
Maintains: Overweight
50 37
10.43 254.75% 7 Aug 8, 2025
RNA Avidity Biosciences
Maintains: Overweight
59 62
46.97 32% 4 Aug 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
42 56
67.74 -17.33% 17 Aug 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
25 21
25.75 -18.45% 10 Aug 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
40 31
28.49 8.81% 10 Aug 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
329 460
456.35 0.8% 8 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
10 22
22.64 -2.83% 15 Jul 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
42 46
65.37 -29.63% 16 Jul 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
15 10
5.9 69.49% 7 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
9 5
0.68 635.29% 4 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
5 4
3.5 14.29% 4 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
45 38
8.55 344.44% 2 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
8 11
7.15 53.85% 10 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
40 8
n/a n/a 11 Mar 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
26 31
5.73 441.01% 6 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
55 26
19.96 30.26% 7 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
435 467
403.12 15.85% 17 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
5 3
3.92 -23.47% 9 Dec 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
110 86
55.43 55.15% 13 Oct 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
83 81
31.21 159.53% 6 Aug 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
93 94
32.06 193.2% 6 Jan 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
75 71
n/a n/a 6 Jul 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
145 228
n/a n/a 3 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 9
16.94 -46.87% 1 Dec 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
16 25
22.56 10.82% 5 Nov 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
60 40
n/a n/a 2 May 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
32 18
8.45 113.02% 2 May 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
72 48
n/a n/a 3 May 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
30 7
n/a n/a 2 Mar 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
208 91
n/a n/a 1 Dec 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
24 8
7.93 0.88% 1 Nov 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
74 79
n/a n/a 1 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
170 34
n/a n/a 2 Mar 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
45 34
n/a n/a 4 May 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
21 9
5.13 75.44% 6 Aug 9, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
74 115
n/a n/a 5 Mar 25, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
48 75
n/a n/a 1 Dec 10, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
152 0
n/a n/a 3 Apr 12, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
n/a
n/a n/a 3 Jan 24, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Underweight
4
n/a n/a 1 Sep 7, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
275
5.41 4983.18% 1 Jan 6, 2017